Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.

Improvement in some but not all domains of cognition during treatment with the atypical antipsychotic drugs clozapine, quetiapine, olanzapine, and risperidone has been reported in some but not all ...

Presentations include results from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive therapy to antidepressants ...

Ingelheim: Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the Broad Institute of ...

Here are the reasons why your child must get ample sleep in his young days. During sleep, your body releases hormones that support brain development. It also helps children retain what they have ...

The advantage of atypical agents for alleviating impaired cognitive function in schizophrenia may be related to actions on 5-HT receptors. 5-HT 1A receptors are one of the most promising targets ...

RL-007: Pro-Cognitive Neuromodulator for Cognitive Impairment Associated with Schizophrenia (CIAS) RL-007 is an orally ...

In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2, ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Russell Fred Dunkley III, who records show has been committed to psychiatric facilities 15 times, was found incompetent to ...

Due to insufficiently treated negative symptoms – including cognitive deficits ... diagnosed can remain functionally impaired. The treatment guidelines for schizophrenia recommend tailored ...